In:
Blood, American Society of Hematology, Vol. 131, No. 12 ( 2018-03-22), p. 1372-1379
Abstract:
AAT infusion produced a high proportion of durable clinical responses in SR-aGVHD. AAT is associated with minimal toxicity and low rates of infection in patients with SR-aGVHD at significant risk for mortality.
Type of Medium:
Online Resource
ISSN:
0006-4971
,
1528-0020
DOI:
10.1182/blood-2017-11-815746
Language:
English
Publisher:
American Society of Hematology
Publication Date:
2018
detail.hit.zdb_id:
1468538-3
detail.hit.zdb_id:
80069-7
Permalink